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INTRODUCTION
The pathogenesis of TSE has still not been completely clarified and discussed. In fact,
in some animal species, other than neuroinvasion, accumulation of PrPre in extraneural
tissues has also been found, suggesting the possibility of concomitant lymphoinvasion. In
particular, in experimentally infected mice, the lymphoreticular system and the spleen are
infected for a long before neuroinvasion. Moreover, infection can be detected in the spleen
1 hour after intraperitoneal infection, suggesting that amplification of the pathogen in the
spleen is necessary before neuroinvasion, at least for some scrapie strains (Beringue et al.,
2000). In a study on prion diffusion in the hamster model, in animals intraperitoneally (i.p.)
infected with the scrapie strain 263K, it was possible to identify a small amount of PrPres in
the spleen of the hamsters. Nevertheless, the concentration of PrPres in the spleen showed
no correlation with the level of PrPres accumulation in any segment of the brain tissue.
According to the authors, the spleen appeared to play a potential but non-essential role in
pathogenesis after intraperitoneal infection in the hamster model (Baldauf et al., 1997). The
aim of this work was to improve and validate an extraction method useful for quantification
of the PrPres in the spleen of prion-infected hamsters.
MATERIALS AND METHODS
20 outbreed Syrian Golden hamsters were used. 16 out of the 20 animals were infected i.p.
with the scrapie strain 263 K by injecting 500 μl of brain homogenate containing 105 ID50.
Four hamsters were sacrificed at 70 days post-infection and the other animals at 1 week after
the onset of clinical signs. The PrPres extraction from the spleen of hamsters was performed,
both with a method routinely used to confirm the diagnosis of BSE in brain tissues (Schaller
et al., 1999) and with a method reported by Wadsworth et al. (2001); the second method
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is based on the ability of sodium phosphotungstic acid (NaPTA), in the presence of MgCl2
and at pH 7.4, to selectively precipitate PrPres from extraneural tissues of vCJD patients.
All the samples were digested with proteinase K at the final concentration of 50 μg/ml. The
extracted prion protein was analysed in Western blotting, using both monoclonal antibody
3F4 (aa. 109–112) and SAF 70 (aa. 142–160).
RESULTS
The spleen of both the positive animal at the highest point of symptomatology and of the
negative ones, extracted and analyzed with the method routinely used for diagnosis in brain
tissues, failed to show any band related to the prion. On the contrary, in the spleens of
infected animals extracted with NaPTA it was possible to identify a weak signal related to
the di-glycosilated band (27–30 kDa), but only after 15 min of radiographic film exposure,
suggesting the possibility of a false positive. The same method was applied to the whole
spleens of 2 infected animals (1 at the terminal stage of the disease and 1 sacrificed 70
days post-infection) and allowed detection of the di-glycosilated band in both samples after
2 min of radiographic film exposure. Interestingly, in the infected animal at the terminal
stage the spleen contains a greater quantity of PrPres than in the animal sacrificed 70 days
post-infection.
Since it has been demonstrated that the hamster spleen can be PrPres negative despite
the presence of PrPres in the CNS (Baldauf et al., 1997), we also analysed the spleens of 8
animals at the terminal stage of disease at the same time. Furthermore, we used two different
monoclonal antibodies (3F4 and SAF 70) to verify the specificity of the reaction.
The spleens were homogenized (10% w/v) in PBS containing 4% Sarcosyl and then
centrifuged at 80 × g for 5 min. 500 μl samples of the resultant supernatant were incubated
for 10 min at 37◦C. The samples were then mixed with 50 U/ml of Benzonase and 1 mM
MgCl2 and incubated for 30 min at 37◦C. NaPTA precipitation was performed by adding
40.65 μl of a stock solution containing 4% NaPTa and 170 mM MgCl2 at pH 7.4. Samples
were incubated at 37◦C for 30 min with constant shaking before centrifugation at 15,800 × g
for 30 min. The supernatant was discarded and the pellet resuspended in 200 μl of PBS
containing 0.1% Sarcosyl and supplemented with 50 μl of 250 mM EDTA in order to
eliminate white precipitates probably consisting of insoluble magnesium salts. Samples
were then centrifuged again at 15,800 × g for 15 min. The pellets were resuspended with
50 μl of PBS containing 0.1% Sarcosyl and digested with proteinase K for 1 hour at 37◦C
with constant shaking; digestion was stopped by the addition of 1 μl 50 mM PMSF. Finally,
after an additional centrifugation at 15,800 × g for 15 min, the pellets were resuspended to
20 μl final volume with Laemmli buffer, transferred to a 100◦C heating block for 10 min
and analyzed by Western blotting.
Two blots (4 samples/blot) were prepared: the first was blocked for 1 hour and incubated
overnight at room temperature with the MoAb 3F4 diluted 1:25,000. The second blot was
blocked overnight at 4◦C and, after washing, was incubated for 1 hour at room temperature
with the MoAb SAF 70 diluted 1:500. After a further incubation for 1 hour at room tem-
perature with the secondary antibody, the reaction was developed with a chemiluminescent
substrate (Immun-Star HRP chemiluminescent, Bio-Rad) for 2 min. As shown in Figure 1,
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Figure 1. Western blotting detection of PrPres in spleens of different i.p. infected hamsters with MoAb
SAF 70. Lane 1–4 PrPres detected starting from 50 mg of spleen tissue
the reaction with MoAb SAF 70 allowed detection of the PrPres band with the expected
pattern, quite identical to that obtained when using brain tissues.
DISCUSSION
In order to detect the presence of PrPres in the spleen of infected hamsters, we used a newly
developed extraction method, before Western blot analysis, allowing the precipitation of
PrPres. The NaPTA treatment applied before proteolysis causes a change in the PK cleavage
site, resulting in the generation of larger PrPres fragments, acting on the N-terminal region
of PrPres. By using this procedure, with some modifications, we succeeded in detecting
the prion protein in the spleen and obtained the expected bands of prion protein, while in
previous reports only very weak signals were obtained. Moreover, it was possible to confirm
that the amount of detectable PrPres in the hamster spleen is very low, suggesting that the
spleen plays a non-essential role for development of the disease in the hamster experimental
model.
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